We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Demonstrates Groundbreaking, New Innovations in Imaging, Diagnostics and Therapy at AACC 2020 Virtual Event

By LabMedica International staff writers
Posted on 14 Dec 2020
Siemens Healthineers (Erlangen, Germany) provided live demonstrations of the company’s groundbreaking, new innovations in imaging, diagnostics and therapy at the all virtual 2020 AACC Annual Scientific Meeting held on December 13-17.

Attendees of the 2020 AACC Virtual Meeting Platform discovered the power of comprehensive multidisciplinary workflow solution by viewing how Siemens’ intelligent analyzers, Atellica Diagnostics IT, Aptio Automation, and the company’s Healthcare Consulting Solutions team combined can take workflow optimization to the next level. More...
Atellica Diagnostics IT provides scalable, easy-to-use solutions to simplify tasks and maximize the effectiveness of the laboratory and its staff. Siemens demonstrated how Atellica Diagnostics IT can enhance visibility, automate processes, and centralize management across instruments, automation, sites, and networks. The company showcased its broad range of hemostasis testing solutions that offer the scalability needed for accurate testing in both low and high-volume testing environments.

Siemens also offered expert-led virtual demonstrations of its broad portfolio of trusted assays for nearly every type of disease that deliver accurate, clinically relevant results, at all access points for patient testing. Attendees were also able to engage in one-on-one conversations, have exclusive access to Siemens’ experts, and participate in live demonstrations of the company’s critical care testing products and chronic disease management at the point of care. The company also demonstrated its full range of antibody, antigen and molecular SARS-CoV-2 tests at the all virtual 2020 AACC.



New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study results show blood protein levels change markedly in childhood and adolescence, with sex differences increasing with age (photo credit: Adobe Stock)

Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

Serum proteins underpin many routine tests used to detect inflammation, hormonal imbalance, cardiovascular disease, and metabolic disorders. Yet pediatric interpretation often relies on adult reference... Read more

Pathology

view channel
Image: Study flowchart. This study developed a multimodal artificial intelligence framework to predict PIK3CA mutations in breast cancer (Jiaxian Miao et al., Cancer Biol Med 23(3): 430–450 (2026). DOI: 10.20892/j.issn.2095-3941.2025.0771)

Multimodal AI Tool Predicts Genetic Alterations to Guide Breast Cancer Treatment

PIK3CA mutations are key biomarkers for selecting phosphoinositide 3-kinase (PI3K)–targeted therapies in breast cancer, yet access to molecular testing can be inconsistent and costly. Conventional polymerase... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.